I thought that was interesting too Mawson. Very strange. I think the asx has decided unless it is immediately revenue raising it isn't price sensitive due to ahz's current position? But these types of announcements were always price sensitive in the past.
News: AHZ Admedus Says Cardiocel 3D And Vascucel Receives European Regulatory Approval, page-6
-
- There are more pages in this discussion • 483 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
